Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia.

Ali YılmazCem MiriliMehmet BiliciSalim Başol Tekin

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

Here, we present a case with NSCLC treated with atezolizumab and with drug-induced ITP and AKI association. Given that atezolizumab and other immune checkpoint inhibitors are being utilized in the treatment of cancers, physicians should be aware of the irAEs, including the AKI and ITP.

Keyphrases

acute kidney injury
drug induced
liver injury
cardiac surgery
small cell lung cancer
primary care
advanced non small cell lung cancer
combination therapy
newly diagnosed
brain metastases